NO20030201D0 - Use of IL-8 receptor antagonists in the treatment of viral infections - Google Patents

Use of IL-8 receptor antagonists in the treatment of viral infections

Info

Publication number: NO20030201D0
Authority: NO; Norway
Prior art keywords: treatment; receptor antagonists; viral infections; infections; viral
Prior art date: 2000-07-18

Application number

NO20030201A

Other languages

Norwegian (no)

Other versions

NO20030201L (en

Inventor

Susan B Dillon

Ruth Talsinger

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-18

Filing date

2003-01-15

Publication date

2003-01-15

2003-01-15 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2003-01-15 Publication of NO20030201D0 publication Critical patent/NO20030201D0/en

2003-03-17 Publication of NO20030201L publication Critical patent/NO20030201L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20030201A 2000-07-18 2003-01-15 Use of IL-8 receptor antagonists in the treatment of viral infections NO20030201L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21905300P	2000-07-18	2000-07-18
PCT/US2001/022328 WO2002005814A1 (en)	2000-07-18	2001-07-16	Use of il-8 receptor antagonists in the treatment of virus infections

Publications (2)

Publication Number	Publication Date
NO20030201D0 true NO20030201D0 (en)	2003-01-15
NO20030201L NO20030201L (en)	2003-03-17

Family

ID=22817645

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030201A NO20030201L (en)	2000-07-18	2003-01-15	Use of IL-8 receptor antagonists in the treatment of viral infections

Country Status (17)

Country	Link
EP (1)	EP1307190A4 (en)
JP (1)	JP2004509852A (en)
KR (1)	KR20030019587A (en)
CN (1)	CN1449285A (en)
AR (1)	AR033830A1 (en)
AU (1)	AU2001273497A1 (en)
BR (1)	BR0112603A (en)
CA (1)	CA2418162A1 (en)
CZ (1)	CZ2003132A3 (en)
HU (1)	HUP0300754A3 (en)
IL (1)	IL153921A0 (en)
MX (1)	MXPA03000500A (en)
NO (1)	NO20030201L (en)
NZ (1)	NZ523659A (en)
PL (1)	PL365886A1 (en)
WO (1)	WO2002005814A1 (en)
ZA (1)	ZA200300474B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060030550A1 (en) *	2004-08-04	2006-02-09	Lithgow Theodore L	Pharmaceutical formulations
WO2015173701A2 (en) *	2014-05-12	2015-11-19	Glaxosmithkline Intellectual Property (No. 2) Limited	Pharmaceutical compositions for treating infectious diseases
WO2021191305A1 (en) *	2020-03-26	2021-09-30	Dompe' Farmaceutici Spa	Cxcl8 inhibitors for use in the treatment of covid-19
EP3884932A1 (en) *	2020-03-26	2021-09-29	Dompe' Farmaceutici S.P.A.	Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) *	2020-12-02	2022-06-08	Dompe' Farmaceutici S.P.A.	Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5547979A (en) *	1992-03-30	1996-08-20	Smithkline Beecham	TNF inhibition
AU3539795A (en) *	1994-08-25	1996-03-14	Medical University Of South Carolina	Methods of treating cold symptoms using pentoxifylline
EP0809492A4 (en) *	1995-02-17	2007-01-24	Smithkline Beecham Corp	Il-8 receptor antagonists
SE9802729D0 (en) *	1998-08-13	1998-08-13	Astra Pharma Prod	Novel Compounds
SE9802937D0 (en) *	1998-09-01	1998-09-01	Astra Pharma Prod	Novel compounds

2001
- 2001-07-16 WO PCT/US2001/022328 patent/WO2002005814A1/en not_active Ceased
- 2001-07-16 IL IL15392101A patent/IL153921A0/en unknown
- 2001-07-16 AU AU2001273497A patent/AU2001273497A1/en not_active Abandoned
- 2001-07-16 CA CA002418162A patent/CA2418162A1/en not_active Abandoned
- 2001-07-16 CZ CZ2003132A patent/CZ2003132A3/en unknown
- 2001-07-16 EP EP01952777A patent/EP1307190A4/en not_active Withdrawn
- 2001-07-16 NZ NZ523659A patent/NZ523659A/en unknown
- 2001-07-16 CN CN01813095A patent/CN1449285A/en active Pending
- 2001-07-16 PL PL01365886A patent/PL365886A1/en not_active Application Discontinuation
- 2001-07-16 KR KR10-2003-7000717A patent/KR20030019587A/en not_active Withdrawn
- 2001-07-16 JP JP2002511746A patent/JP2004509852A/en not_active Withdrawn
- 2001-07-16 AR ARP010103395A patent/AR033830A1/en not_active Application Discontinuation
- 2001-07-16 HU HU0300754A patent/HUP0300754A3/en unknown
- 2001-07-16 BR BR0112603-2A patent/BR0112603A/en not_active IP Right Cessation
- 2001-07-16 MX MXPA03000500A patent/MXPA03000500A/en unknown
2003
- 2003-01-15 NO NO20030201A patent/NO20030201L/en not_active Application Discontinuation
- 2003-01-17 ZA ZA200300474A patent/ZA200300474B/en unknown

Also Published As

Publication number	Publication date
HUP0300754A2 (en)	2003-08-28
KR20030019587A (en)	2003-03-06
CZ2003132A3 (en)	2003-09-17
NO20030201L (en)	2003-03-17
HUP0300754A3 (en)	2009-03-02
BR0112603A (en)	2004-08-24
NZ523659A (en)	2006-01-27
JP2004509852A (en)	2004-04-02
ZA200300474B (en)	2004-08-17
EP1307190A4 (en)	2007-08-22
EP1307190A1 (en)	2003-05-07
AU2001273497A1 (en)	2002-01-30
PL365886A1 (en)	2005-01-10
MXPA03000500A (en)	2003-06-24
IL153921A0 (en)	2003-07-31
AR033830A1 (en)	2004-01-07
CA2418162A1 (en)	2002-01-24
WO2002005814A1 (en)	2002-01-24
CN1449285A (en)	2003-10-15

Publication	Publication Date	Title
DE60135144D1 (en)	2008-09-11	Interconnects
DE60143422D1 (en)	2010-12-23	INTERCONNECTS
DE60026949D1 (en)	2006-05-18	Interconnects
ID30590A (en)	2002-01-03	ONCE USE SHORT TYPE OF SHORT-PANTS
DE50112057D1 (en)	2007-04-05	Cleaning-friendly glass ceramic body
DE60135231D1 (en)	2008-09-18	COMPOSITE NONWOVEN
EE200200400A (en)	2003-10-15	Corticotropin releasing factor antagonists
EP1174399A4 (en)	2003-04-02	CERAMIC STRUCTURE
DE60102506D1 (en)	2004-05-06	Interconnects
DE60116491D1 (en)	2006-03-30	WAVY STRUCTURE
DK1373256T3 (en)	2005-10-10	CCR5 antagonists useful in the treatment of AIDS
AR027945A1 (en)	2003-04-16	USE OF PRAMIPEXOL IN THE TREATMENT OF ADDICTION DISORDERS
NO20030239L (en)	2003-03-18	Modified virus
DK1458399T3 (en)	2012-11-12	Pregnancy steroids for use in the treatment of CNS diseases
DK1345598T3 (en)	2008-02-04	The use of rosiglitazone in the treatment of psychiatric disorders
DE60119875D1 (en)	2006-06-29	Interconnects
DE60109670D1 (en)	2005-05-04	Interconnects
DE60106146D1 (en)	2004-11-11	Interconnects
DE60112673D1 (en)	2005-09-22	Interconnects
DE60100973D1 (en)	2003-11-20	Interconnects
DE60107134D1 (en)	2004-12-23	Interconnects
PT1220858E (en)	2004-03-31	OXAZINOQUINOLONES UTEIS FOR THE TREATMENT OF VIRAL INFECTIONS
NO20030201D0 (en)	2003-01-15	Use of IL-8 receptor antagonists in the treatment of viral infections
DK1257278T3 (en)	2006-06-12	Use of mirtazapine for the treatment of sleep disorders
NO20032769D0 (en)	2003-06-18	Combination method for the treatment of viral infections

Legal Events

Date	Code	Title	Description
2009-02-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application